Molecular Imaging

Targeted alpha therapy’s ‘elite 8’ radionuclides

By Will Morton

A select group of eight radionuclides holds hopes for an emerging cancer treatment in nuclear medicine called targeted alpha therapy (TAT).

March 26, 2025

New method proposed for diagnosing Alzheimer’s

By Will Morton

Researchers in Germany have proposed a new approach derived from brain PET imaging for diagnosing and staging Alzheimer’s disease.

March 25, 2025

Whole-body PET visualizes COVID-19 infection

By Will Morton

Researchers in France have developed a PET imaging approach for longitudinal tracking of the virus that causes COVID-19.

March 24, 2025

PSMA-PET/CT identifies 'atypical' metastases in prostate cancer patients

By Will Morton

PET/CT scans with an experimental PSMA imaging agent can identify supraclavicular nodal metastasis in newly diagnosed prostate cancer patients.

March 21, 2025

IAEA touts radionuclide development activities

By Will Morton

The IAEA has highlighted its worldwide activities to meet increasing demands for alpha-emitting radionuclides for use in Targeted Alpha Therapy.

March 18, 2025

FAPI-PET superior to FDG-PET for detecting bone cancer

By Will Morton

PET/CT imaging with fibroblast activation protein inhibitor (FAPI) detects more bone metastases than FDG-PET/CT in patients with different types of cancer.

March 17, 2025

New analysis supports use of FES-PET in breast cancer patients

By Will Morton

F-18 fluoroestradiol (FES)-PET scans can predict whether endocrine therapy could be effective in women with estrogen receptor-positive breast cancer.

March 13, 2025

What’s your brain like on a vanilla milkshake?

By Will Morton

A controlled “feeding” PET study by researchers at the National Institutes of Health (NIH) has called into question the theory that ultraprocessed foods elicit brain responses akin to addictive drugs.

March 12, 2025

Hormone therapy linked to tau accumulation in older women

By Will Morton

A PET study reveals that women over the age of 70 who took menopausal hormone therapy more than a decade prior have faster brain tau accumulation.

March 7, 2025

Ac-225: From nuclear waste to cancer treatment

By Will Morton

U.S. Department of Energy (DOE) efforts to dispose of spent nuclear waste left over from the Cold War has turned into a boon for supplies of actinium-225 (Ac-225).

March 5, 2025

FES-PET shows promise staging patients with low-grade breast cancer

By Will Morton

F-18 fluoroestradiol (FES) PET may improve staging of grade 1 or 2 estrogen receptor-positive breast cancer compared with F-18 FDG-PET.

March 4, 2025

FAPI-PET/CT shows promise in gynecological cancers

By Will Morton

Fibroblast activation protein inhibitor (FAPI) PET/CT appears superior to FDG-PET/CT for imaging gynecological cancers.

March 3, 2025

Page 1 of 601

Next Page